Malignant pheochromocytoma: A diagnostic and therapeutic dilemma

• Published in: International journal of surgery case reports 2021-06, Vol.83, p.106009-106009, Article 106009
• Main Authors: Jandou, Issam, Moataz, Amine, Dakir, Mohammed, Debbagh, Adil, Aboutaieb, Rachid
• Format: Article
• Language: English
• Subjects: Adrenal pheochromocytoma; Adrenalectomy; Case Series; malignant pheochromocytoma; Menard triad; Metastasis; Methoxylated derivative
• ISSN: 2210-2612; 2210-2612
• DOI: 10.1016/j.ijscr.2021.106009

Malignant pheochromocytomas are rare endocrine tumors that develop within chromaffin tissue. The diagnosis of malignancy is based on neoplastic recurrence or the presence of metastasis in organs that lack chromaffin tissue. We report a series of four cases because of their diagnostic and therapeutic particularities. we describe four clinical cases of patients with malignant pheochromocytoma whose Menard triad “headache-palpitations-sweating” was present in three out of four patients, the methoxylated derivatives were measured in 4 patients, 3 of which had high values, all of our patients carried out a CT scan which objectified signs of malignancy, MRI was performed on a single patient; presenting with a neoplastic recurrence; looking for a locoregional invasion. Pheochromocytoma (PC) is a rare neuroendocrine tumor derived from the chromaffin cells of the adrenal medulla. Its annual incidence is 2 to 8 per million adults. A peak frequency is observed between 30 and 40 years of age. Approximately 10% of pheochromocytomas are malignant and in 10% of cases, bilateral localization is observed. Criteria for malignancy include the invasion of neighboring organs, a large tumor, the presence of lymphadenopathy on imaging, or fixation on scintigraphy. Surgery for MAP is not always curative. In the case of multiple liver metastases, treatment is based on adrenalectomy, which can be effectively combined with chemoembolization, cryoablation, or radiofrequency techniques. The main prognostic factors of the malignant pheochromocytomas are a large tumor volume, the existence or number of visceral metastases, and the presence of a mutation in the SDHB (Succinate dehydrogenase B) gene. •Malignant pheochromocytomas are rare endocrine tumors that develop within chromaffin tissue.•A very large part of pheochromocytomas are of genetic origin which can be part of hereditary syndromes.•Criteria for malignancy include the invasion of neighboring organs, a large tumor, the presence of lymphadenopathy on imaging, or fixation on scintigraphy.•Adequate management of this pathology requires a multidisciplinary consultation meeting